Table 3.
MicroRNA | Catalysts/Amplification Agents | Platform | Substrat or Reagent | Technique | Linear Range | LOD | Real-Samples Application | References |
---|---|---|---|---|---|---|---|---|
miRNA-21 | ALP/DNA-linked GO–AuNPs | GCE/MgO/AuNPs | AAP | DPV | 0.1–100 fM | 50 aM | Spiked human serum | [98] |
miRNA -21 | ALP/HCR | AuE | α-NP | SWV | 1 fM–100 pM | 0.56 fM | Spiked HEK293T cells | [104] |
miRNA-21 | ALP/CHA-WO3-Gr | GCE/WO3-Gr/AuNPs | Ascorbic acid 2-phosphate | DPV | 0.1 fM–100 pM | 0.05 fM | Serum samples from breast cancer patients | [111] |
miRNA -21 | HRP/AuNPs | AuE | H2O2 | Amperometry | 0.1 fM–100 pM | 43.3 aM | A549 tumor cells | [113] |
miRNA-155 | ALP/CHA | GCE/MWCNTs PtNPs | Phosphate ion Molybdophosphate anion |
DPV | 10 fM–1 nM | 1.64 fM | Cervical cancer cells and human breast cancer cell lines | [131] |
miRNA-155 | ALP/- | SCPE/Fe3O4 | AAP | DPV | 0.6–9 ng/mL | 29 pM | Spiked human serum | [132] |
miRNA-21 | HRP/- | SCPE/Fe3O4 | H2O2 | Amperometry | 1.0–100 pM | 10 aM | MCF-7 cells | [116] |
miRNA -155 | HRP/GQDs | AuE | TMB | Amperometry | 1fM–00 pM | 0.14 fM | Spiked human serum | [118] |
miRNA-21, let-7a & miRNA-31 | HRP/HCR | SPCE/Fe3O4 | H2O2 | Amperometry | 1.2–100 pM | 0.66 pM | MCF-7 cells | [133] |
miRNA-21 | HRP/- | SPCE/Fe3O4 | H2O2 | Amperometry | 3.0 to 100 nM | 0.91 nM | MCF-7 cells | [134] |
miRNA-21 | Copper (II) complex/HCR | GCME/Fe3O4 | TMB | DPV | 100 aM–100 nM | 33 aM | human serum samples from breast cancer | [135] |
miRNA-155 | Cu-MOFs/AuNPs | Au-PWE | Glucose | DPV | 1 fM–10 nM | 0.35 fM | Spiked human serum | [120] |
miRNA-21 | Sn-In2O3/- | AuE | O2 | DPV | 5 pM–0.5 fM | 1.92 fM | A549 and HeLa cell lines | [122] |
miRNA-21 | G-quadruplex−hemin/- | AuE | H2O2 | DPV | 0.1 fM–0.1 pM | 0.04 fM | Human serum samples from breast cancer | [128] |
miRNA-21 | G-quadruplex−hemin/HCR | AuE/SWCNT-ox/NDs/SWCNTs-ox/AuNPs | H2O2 | DPV | 10 fM–1.0 nM | 1.95 fM | Spiked human serum | [129] |
Abbreviations: GCE, glassy carbone electrode; NDs, nanodiamonds; MB, magnetic beads; SWCNTs, single-walled carbon nanotubes; α-NP, α-naphtyl phosphate; AAP, ascorbic acid 2-phosphate; WO3-Gr, tungsten oxide-graphene composites; AA, ascorbic acid; ALP, alkaline phosphatase; CHA, catalytic hairpin assembly; DPV, differential pulse voltammetry; MgO, magnesium oxide; GO, graphene oxide, AuNPs, gold nanoparticles; AuE, gold electrode; HCR, hybridization chain reaction; SWV, square wave voltammetry; HEK293T cells, from human embryonic kidney 293T cells; SPCE, screen-printed carbon electrodes; H2O2, hydrogen peroxide; HRP, horseradish peroxidase; MCF-7 cells, human breast adenocarcinoma cell line; TMB, 3,3′,5,5′-tetramethylbenzidine; GQDs, graphene quantum dots; A549, human lung carcinoma cells; HeLa cells, human cervical cancer cells; Au-PWE, gold-paper working electrode; Cu-MOFs, copper-based metal–organic frameworks; G-quadruplex−hemin, Guanine-quadruplex−hemin; MDA-MB-231, human breast cancer cell lines, Sn-In2O3, tin-doped indium oxide particles. MWCNTs, multi-walled carbon nanotube, platinum nanoparticles, PtNPs; magnetic nanoparticles, Fe3O4.